Who are Alector, Inc.'s main suppliers?

Alector, Inc. (ALEC) key suppliers include: TD-COWEN, Hercules Capital, Inc.. View the full supplier network at chainsifter.com/chain/ALEC.

Who are Alector, Inc.'s major customers?

Alector, Inc. (ALEC) key customers include: Gain Therapeutics, Inc., Gain Therapeutics, Inc., Hercules Capital, Inc., Hercules Capital, Inc., Eli Lilly and Company and 7 more. View the full customer network at chainsifter.com/chain/ALEC.

What sector is Alector, Inc. in?

Alector, Inc. (ALEC) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Alector, Inc. Supply Chain Data (ALEC): 16 Verified Relationships

2Suppliers

12Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Alector, Inc. (ALEC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

17Total relationships

3Distinct source URLs

4High confidence

0.739Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Alector, Inc. Suppliers

Ticker	Name	Confidence	Evidence
TD-COWEN	TD-COWEN	90%	In the ordinary course of business, TD Cowen and/or its affiliates have provided, and may in the future provide, various investment banking and other financial services for us for which services they…
HTGC	Hercules Capital, Inc.	72%	Reciprocal relationship from HTGC graph: Reciprocal relationship from ALEC graph: Reciprocal relationship from HTGC graph: Reciprocal relationship from ALEC graph: Reciprocal relationship from HTGC g…

Alector, Inc. Customers

Ticker	Name	Confidence	Evidence
GANX	Gain Therapeutics, Inc.	72%	t on our business and could potentially cause us to cease operations. We may not be successful in our efforts to further develop our current product candidates. For example, clinical trials of our pr…
GANX	Gain Therapeutics, Inc.	72%	Reciprocal relationship from GANX graph: Reciprocal relationship from ALEC graph: t on our business and could potentially cause us to cease operations. We may not be successful in our efforts to furt…
HTGC	Hercules Capital, Inc.	72%	h pipeline. We initiated that reduction in force impacting approximately 25 employees across the organization. On October 21, 2025, we committed to a plan to reduce our workforce by approximately 47%…
HTGC	Hercules Capital, Inc.	72%	Reciprocal relationship from HTGC graph: Reciprocal relationship from ALEC graph: h pipeline. We initiated that reduction in force impacting approximately 25 employees across the organization. On Oct…
LLY	Eli Lilly and Company	72%	Reciprocal relationship from LLY graph: Reciprocal relationship from ALEC graph: t on our business and could potentially cause us to cease operations. We may not be successful in our efforts to furth…
LLY	Eli Lilly and Company	72%	t on our business and could potentially cause us to cease operations. We may not be successful in our efforts to further develop our current product candidates. For example, clinical trials of our pr…
VYGR	Voyager Therapeutics, Inc.	72%	Reciprocal relationship from VYGR graph: Reciprocal relationship from ALEC graph: t on our business and could potentially cause us to cease operations. We may not be successful in our efforts to furt…
VYGR	Voyager Therapeutics, Inc.	72%	t on our business and could potentially cause us to cease operations. We may not be successful in our efforts to further develop our current product candidates. For example, clinical trials of our pr…
ABBVIE-BIOTECHNOLOGY-LTD	ABBVIE-BIOTECHNOLOGY-LTD	62%	pects. • Raising additional capital may cause dilution to our existing stockholders, restrict our operations, or require us to relinquish rights to our technologies or product candidates. Risks Relat…
COMPANY-LLC	COMPANY-LLC	62%	h pipeline. We initiated that reduction in force impacting approximately 25 employees across the organization. On October 21, 2025, we committed to a plan to reduce our workforce by approximately 47%…
DNLI	Denali Therapeutics Inc.	62%	Reciprocal relationship from DNLI graph: Reciprocal relationship from ALEC graph: Reciprocal relationship from DNLI graph: Reciprocal relationship from ALEC graph: Reciprocal relationship from DNLI g…
USA-LLC	USA-LLC	62%	nd increase our costs and expenses. Our operations, and those of our collaborators, CROs, CDMOs, suppliers, and other contractors and consultants, could be subject to events beyond our control, such …

Alector, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ALEC-DEBT-7671	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2019-12-31.
ALEC-DEBT	Debt stack $9.8M	90%	Market cache reports total debt of $9.8M.

Alector, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Alector, Inc..

Alector, Inc. Ownership

Holder	Name	Confidence	Evidence
ALEC-OWNER-TCG-CROSSOVER-MANAGEMENT-LLC	TCG Crossover Management, LLC	90%	13F overlay lists TCG Crossover Management, LLC as top holder; 139 tracked holders.

Alector, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
HTGC	Hercules Capital, Inc.	100.00	1	['customer', 'supplier']
LLY	Eli Lilly and Company	100.00	1	['customer']
DNLI	Denali Therapeutics Inc.	100.00	1	['customer']
GANX	Gain Therapeutics, Inc.	100.00	1	['customer']
VYGR	Voyager Therapeutics, Inc.	100.00	1	['customer']
CYTOF	Altamira Therapeutics Ltd.	50.00	2
DAWN	Day One Biopharmaceuticals Inc	50.00	2
BTCW	WisdomTree Bitcoin Fund	50.00	2
FHTX	Foghorn Therapeutics Inc.	50.00	2
AXSM	Axsome Therapeutics, Inc.	50.00	2
BEAM	Beam Therapeutics Inc.	50.00	2
GSOL	Grayscale Solana Staking ETF	50.00	2
AZI	Autozi Internet Technology (Global) Ltd.	50.00	2
DSGN	Design Therapeutics, Inc.	50.00	2
EDSA	Edesa Biotech, Inc.	50.00	2
BIOA	BioAge Labs, Inc.	50.00	2
HMDCF	HUTCHMED (China) Ltd	50.00	2
DIDIY	DiDi Global Inc.	50.00	2
LGNZZ	LIGAND PHARMACEUTICALS INC	50.00	2
AKTS	Aktis Oncology, Inc.	50.00	2

Alector, Inc. Supply Chain